Durham, NC – According to filings with the U.S. Securities and Exchange Commission, Dance Biopharm Holdings is raising $59,200,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Anne Whitaker played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Dance Biopharm Holdings

Dance Biopharm is a private company focused on developing novel inhaled formulations of biologics to treat severe and chronic diseases. The company’s novel inhalation delivery technology platform may be utilized with liquid formulations of biologics with the goal of providing effective and convenient treatment options to patients along with wireless connectivity to improve disease management. Dance, headquartered in Durham, NC, was founded by John Patton, Ph.D., who has over 25 years of experience developing numerous inhaled therapies.

To learn more about Dance Biopharm Holdings, visit http://www.dancebiopharm.com/

Contact:
Anne Whitaker, Chief Executive Officer
415-769-4200
awhitaker@dancebiopharm.com
https://www.linkedin.com/in/annewhitaker1/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved